Metabolically labile cannabinoid esters: A 'soft drug' approach for the development of cannabinoid-based therapeutic drugs

F. Minutolo; M. G. Cascio; I. Carboni; T. Bisogno; G. Prota; S. Bertini; M. Digiacomo; M. Bifulco; V. Di Marzo; M. Macchia

doi:10.1016/j.bmcl.2007.06.055

Metabolically labile cannabinoid esters: A 'soft drug' approach for the development of cannabinoid-based therapeutic drugs

F. Minutolo^*, M. G. Cascio, I. Carboni, T. Bisogno, G. Prota, S. Bertini, M. Digiacomo, M. Bifulco, V. Di Marzo, M. Macchia

^*Corresponding author for this work

Medical Sciences

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

Biphenylic ester derivatives, designed by using a 'soft-drug' approach, proved to possess good binding properties toward cannabinoid CB₁ and CB₂ receptors and, at the same time, their metabolically labile ester portion would promote a rapid systemic inactivation. This may constitute a possible solution to the psychotropic side effects encountered when cannabinoids are therapeutically employed as local analgesic or antiglaucoma agents.

Original language	English
Pages (from-to)	4878-4881
Number of pages	4
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	17
Issue number	17
Early online date	20 Jun 2007
DOIs	https://doi.org/10.1016/j.bmcl.2007.06.055
Publication status	Published - 1 Sept 2007

Keywords

Cannabinoids
CB
Retrometabolic
Soft-drugs

Access to Document

10.1016/j.bmcl.2007.06.055

Cite this

Minutolo, F., Cascio, M. G., Carboni, I., Bisogno, T., Prota, G., Bertini, S., Digiacomo, M., Bifulco, M., Di Marzo, V., & Macchia, M. (2007). Metabolically labile cannabinoid esters: A 'soft drug' approach for the development of cannabinoid-based therapeutic drugs. Bioorganic and Medicinal Chemistry Letters, 17(17), 4878-4881. https://doi.org/10.1016/j.bmcl.2007.06.055

Minutolo, F, Cascio, MG, Carboni, I, Bisogno, T, Prota, G, Bertini, S, Digiacomo, M, Bifulco, M, Di Marzo, V & Macchia, M 2007, 'Metabolically labile cannabinoid esters: A 'soft drug' approach for the development of cannabinoid-based therapeutic drugs', Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 17, pp. 4878-4881. https://doi.org/10.1016/j.bmcl.2007.06.055

@article{84291db141b846e5aa6fa05895cbccf2,

title = "Metabolically labile cannabinoid esters: A 'soft drug' approach for the development of cannabinoid-based therapeutic drugs",

abstract = "Biphenylic ester derivatives, designed by using a 'soft-drug' approach, proved to possess good binding properties toward cannabinoid CB1 and CB2 receptors and, at the same time, their metabolically labile ester portion would promote a rapid systemic inactivation. This may constitute a possible solution to the psychotropic side effects encountered when cannabinoids are therapeutically employed as local analgesic or antiglaucoma agents.",

keywords = "Cannabinoids, CB, Retrometabolic, Soft-drugs",

author = "F. Minutolo and Cascio, {M. G.} and I. Carboni and T. Bisogno and G. Prota and S. Bertini and M. Digiacomo and M. Bifulco and {Di Marzo}, V. and M. Macchia",

year = "2007",

month = sep,

day = "1",

doi = "10.1016/j.bmcl.2007.06.055",

language = "English",

volume = "17",

pages = "4878--4881",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Limited",

number = "17",

}

TY - JOUR

T1 - Metabolically labile cannabinoid esters

T2 - A 'soft drug' approach for the development of cannabinoid-based therapeutic drugs

AU - Minutolo, F.

AU - Cascio, M. G.

AU - Carboni, I.

AU - Bisogno, T.

AU - Prota, G.

AU - Bertini, S.

AU - Digiacomo, M.

AU - Bifulco, M.

AU - Di Marzo, V.

AU - Macchia, M.

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Biphenylic ester derivatives, designed by using a 'soft-drug' approach, proved to possess good binding properties toward cannabinoid CB1 and CB2 receptors and, at the same time, their metabolically labile ester portion would promote a rapid systemic inactivation. This may constitute a possible solution to the psychotropic side effects encountered when cannabinoids are therapeutically employed as local analgesic or antiglaucoma agents.

AB - Biphenylic ester derivatives, designed by using a 'soft-drug' approach, proved to possess good binding properties toward cannabinoid CB1 and CB2 receptors and, at the same time, their metabolically labile ester portion would promote a rapid systemic inactivation. This may constitute a possible solution to the psychotropic side effects encountered when cannabinoids are therapeutically employed as local analgesic or antiglaucoma agents.

KW - Cannabinoids

KW - CB

KW - Retrometabolic

KW - Soft-drugs

UR - http://www.scopus.com/inward/record.url?scp=34547496849&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2007.06.055

DO - 10.1016/j.bmcl.2007.06.055

M3 - Article

C2 - 17604171

AN - SCOPUS:34547496849

SN - 0960-894X

VL - 17

SP - 4878

EP - 4881

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

IS - 17

ER -

Metabolically labile cannabinoid esters: A 'soft drug' approach for the development of cannabinoid-based therapeutic drugs

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this